Whitepaper: Data management in ADC development
Posted: 18 November 2021 | ACD/Labs | No comments yet
Critically examining data management in ADC development and research.
Antibody-Drug Conjugates (ADCs) have tremendous potential as therapeutics, but they face unique challenges. Due to their complexity, ADCs require multiple analytical techniques to characterise their structures, drug antibody ratios and purity. Drawing conclusions using data from incompatible file formats is burdensome and time-consuming. This whitepaper explores issues with analytical data generated throughout the ADC development process and tools to improve analytical data management.
Related content from this organisation
Related topics
Analytical techniques, Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Data integrity, Drug Delivery Systems, Informatics, Manufacturing, Proteomics, Research & Development (R&D)
